Suggestions
Carla Mellough
Director of Pharmacology at PYC Therapeutics. Head of the Retinal Organoid Laboratory at the Lions Eye Institute.
Carla Mellough is the Director of Pharmacology at PYC Therapeutics, a company focused on developing treatments for genetic diseases using RNA-based approaches.1 Her professional background includes:
Education and Research
Carla holds a BSc in Anatomy and Human Biology and a PhD in Neuroscience from the University of Western Australia.2 She has been involved in academic research, with a particular focus on:
- Retinal diseases and development
- Gene, drug, and cell-based therapies for Usher syndrome
- Mechanisms of cone migration in the mammalian retina3
Current Role
As Director of Pharmacology at PYC Therapeutics, Carla leads the development of treatments for genetic diseases. Her responsibilities likely include:
- Overseeing pharmacological aspects of drug development
- Guiding research strategies for RNA-based therapies
- Managing teams working on genetic disease treatments
Research Affiliations
Carla has been associated with:
- Lions Eye Institute in Western Australia2
- Frontiers, where she has contributed to scientific publications3
Impact and Recognition
Carla's expertise in retinal biology and genetic diseases has positioned her as a key figure in the field. Her work at PYC Therapeutics involves translating scientific research into potential therapeutic applications, particularly in the area of RNA-based treatments for genetic disorders.
